Fundraising FoxCocoon Biotech, Inc.
Boston, US · Founded 2013 · Delaware corporation · 2 known investors
Find your way into Cocoon Biotech, Inc.
Sign up to see every warm intro you have to Cocoon Biotech, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cocoon Biotech, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AT
Ailis Tweed-KentNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$7.8M disclosed across 5 rounds · 2014–2021
▶$385.2KraisedDec 2021 · 6 investors · BiotechnologyRule 506(b)
▶$385.2KraisedDec 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles KoppelDirector
- Mary ThistleDirector
- Annalisa JenkinsDirector
- Ailis Tweed-KentExecutive Officer, Director
- Offering amount
- $1000K
- Amount sold
- $385.2K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$865.4KraisedOct 2020 · 4 investors · BiotechnologyRule 506(b)
▶$865.4KraisedOct 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mary ThistleDirector
- Annalisa JenkinsDirector
- Ailis Tweed-KentExecutive Officer, Director
- Offering amount
- $865.4K
- Amount sold
- $865.4K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedNov 2019 · 32 investors · BiotechnologyRule 506(b)
▶$4.5MraisedNov 2019 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Grace ColonDirector
- Ailis Tweed-KentExecutive Officer, Director
- Mary ThistleDirector
- Annalisa JenkinsDirector
- Amount sold
- $4.5M
- Minimum investment
- $5K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedOct 2015 · 18 investors · BiotechnologyRule 506(b)
▶$1.8MraisedOct 2015 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ailis Tweed-KentExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.8M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$200KraisedJun 2014 · 3 investors · BiotechnologyRule 506(b)
▶$200KraisedJun 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ailis Tweed-KentExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $200K
- Minimum investment
- $1K
- Proceeds to insiders
- $12.5K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Cocoon Biotech, Inc.'s investors?
- Cocoon Biotech, Inc.'s investors include Argonautic Ventures, iSelect Fund.
- How much funding has Cocoon Biotech, Inc. raised?
- Cocoon Biotech, Inc. has disclosed $7.8M raised across 5 rounds.
- Where is Cocoon Biotech, Inc. headquartered?
- Cocoon Biotech, Inc. is headquartered in Boston, US.